Outset Medical reports disappointing earnings in second-quarter By Investing.com
Outset Medical (NASDAQ: OM), a medical technology company, reported second-quarter earnings for 2024 that missed market expectations, primarily due to a slower ramp-up of its TabloCart product and an extended sales cycle.
Despite these…
